Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update

Go back to Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update

Forte Biosciences (FBRX) Reports Q3 Loss of $0.26

November 13, 2023 4:21 PM EST

Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($0.26).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

... More